This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Driving and blepharospasm

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Group 1 entitlement:

  • Must not drive and must notify the DVLA.
  • Driving is not usually licensed if the condition is severe and affects vision, even if treated.
  • A consultant specialist's opinion will be sought by the DVLA.
  • Driving may be licensed if the condition is mild, subject to return of satisfactory medical reports.
  • Control of mild blepharospasm with botulinum toxin may lead to licensing if the treatment does not produce side effects that are otherwise disqualifying, such as uncontrollable diplopia.
  • The DVLA should be informed of any change - and any deterioration in condition must be notified

For more details guidance may be obtained from the publication "At a Glance Guide to the Current Medical Standards of Fitness to Drive" and the website www.dvla.gov.uk.

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.